A novel form of the human manganese superoxide dismutase protects rat and human livers undergoing ischemia and reperfusion injuries.

In conclusion, rMnSOD represents a new and highly effective therapy to significantly upgrade liver procurement for transplantation.

Source: Clinical Science - April 22, 2014 Category: Biomedical Science Authors: D Hide, M Ortega-Ribera, A Fernandez-Iglesias, C Fondevila, M Josepa Salvado, L Arola, J Carlos Garcia-Pagan, A Mancini, J Bosch, J Gracia-Sancho Source Type: research